Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
65 results about "Monitor glucose" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The other test is a general blood glucose test. It is often referred to as self-monitoring of blood glucose. Using a blood glucose monitor to do regular testing can help you improve control of your blood sugar levels.
Integrated receiver for continuous analyte sensor
InactiveUS20080287765A1Simpler and few componentReduce errorsEndoradiosondesCatheterGlucose sensorsData stream
A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.
Owner:DEXCOM INC
Integrated receiver for continuous analyte sensor
InactiveUS20080287764A1Simpler and few componentReduce errorsPharmaceutical delivery mechanismEndoradiosondesGlucose sensorsData stream
A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.
Owner:DEXCOM INC
Integrated receiver for continuous analyte sensor
ActiveUS20080287766A1Simpler and few componentReduce errorsEndoradiosondesCatheterGlucose sensorsData stream
A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.
Owner:DEXCOM INC
Sensor head for use with implantable devices
InactiveUS7471972B2Minimizing negative potential extremesImprove solubilityMicrobiological testing/measurementMaterial analysis by electric/magnetic meansElectrochemical responseAnalyte
The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.
Owner:DEXCOM INC
Method and apparatus for monitoring glucose levels in a biological tissue
ActiveUS7254429B2Convenient amountLow lightDiagnostic recording/measuringSensorsContinuous scanningConcentrations glucose
In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.
Owner:MASIMO CORP
Membrane for use with implantable devices
The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided.
Owner:DEXCOM
Membrane for use with implantable devices
ActiveUS20100087724A1Bioreactor/fermenter combinationsBiological substance pretreatmentsAnalyteBiointerface
The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided.
Owner:DEXCOM INC
Transcutaneous analyte sensor
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. In some embodiments, a device is provided for monitoring glucose concentration in a host, including a continuous glucose sensor and an integrated receiver including a single point glucose monitor. In some embodiments, a computer system is provided that determines a rate of change of continuous analyte sensor data.
Owner:DEXCOM INC
Analyte sensor
ActiveUS20070027370A1Increase liquid volumeLarge flowMicrobiological testing/measurementCatheterAnalyteBiointerface
Biointerface membranes are provided which can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device incorporating such membranes are provided.
Owner:DEXCOM
Method of monitoring glucose level
The method of monitoring or measuring the concentration of glucose level in human and animal blood uses a non-invasive technique and includes measurements of the speed of sound through the blood, the conductivity of the blood, and the heat capacity of the blood, or by non-invasive measurement of any other parameters that can be used to calculate the glucose level. Thereafter, the glucose level for each of the three measurements is calculated and the final glucose value is determined by a weighted average of the three calculated glucose values.
Owner:JMS DIVERSIFIELD HLDG
Analyte sensor
The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.
Owner:DEXCOM
Methods of monitoring glucose levels in a subject and uses thereof
Methods of frequently monitoring glucose amounts and / or concentrations in a subject who is at risk for hypoglycemia, hyperglycemia, and / or glucose level fluctuations that put the subject at risk are provided. Also provided are methods of monitoring the effects of one or more pharmaceutical compositions on the levels of glucose in a subject.
Owner:ANIMAS TECH +1
Highly catalytic screen-printing ink
ActiveUS7018568B2Easy to produceConductive layers on insulating-supportsConductive materialConductive polymerPrinting ink
The invention is directed to conductive polymer compositions, catalytic ink compositions (e.g., for use in screen-printing), electrodes produced by deposition of an ink composition, methods of making, and methods of using thereof. An exemplary ink material comprises platinum black and / or platinum-on-carbon as the catalyst, graphite as a conducting material, a polymer binding material, and an organic solvent. The polymer binding material is typically a copolymer of hydrophilic and hydrophobic monomers. The conductive polymer compositions of the present invention can be used, for example, to make electrochemical sensors. Such sensors can be used in a variety of analyte monitoring devices to monitor analyte amount or concentrations in subjects, for example, glucose monitoring devices to monitor glucose levels in subjects with diabetes.
Owner:LIFESCAN IP HLDG LLC +1
Coherence-gated optical glucose monitor
ActiveUS20050075547A1Reduce volatilitySimplify structure and optical configurationScattering properties measurementsDiagnostics using tomographyMonitor glucoseBlood sugar
This application describes designs, implementations, and techniques for optically monitoring glucose levels of patients without taking blood samples.
Owner:TOMOPHASE
Method and apparatus for monitoring glucose levels in a biological tissue
ActiveUS20080021293A1Convenient amountLow lightDiagnostic recording/measuringSensorsBLOOD FILLEDConcentrations glucose
Owner:MASIMO CORP
Integrated blood sampling analysis system with multi-use sampling module
A simple, miniaturized, disposable acquisition and test module for monitoring glucose or other analytes successively for multiple times is described. The apparatus is designed to collect and test small volumes of blood in a single step. Many samples can be acquired and analyzed using a single disposable sampling module, minimizing the number of disposables and improving ease of use of the system.
Owner:SANOFI AVENTIS DEUT GMBH
Method and apparatus for monitoring glucose levels in a biological tissue
ActiveUS20060063988A1Different scattering propertyReduce noiseDiagnostic recording/measuringSensorsContinuous scanningConcentrations glucose
In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.
Owner:MASIMO CORP
Personal digital assistant or organizer for monitoring glucose levels
ActiveUS20190216319A1Evaluation of blood vesselsMedical automated diagnosisAddress bookMonitor glucose
The present disclosure provides an electronic device that includes at least one sensor indicative of a physiological condition of a user, the at least one sensor worn by a patient. The electronic device can further include a location determination module configured to determine a location of a patient. The electronic device can receive a measured information from the sensor and determine if the physiological condition of the user indicates an urgent medical need. When the physiological condition of the user indicates an urgent medical need, the electronic device can contact emergency services and access and contact one or more of a contact in an electronic address book associated with the processing system. The electronic device can provide a location of the user based on information determined by the location determination module.
Owner:CERCACOR LAB INC
Iontophoresis system
The present invention provides an iontophoresis system for non-invasively taking a physiological substance out of the living body, the system being suitably used for the mucous membrane. The present iontophoresis system non-invasively takes a physiological substance out of a living body. The system includes a plurality of electrode structures and a power supply device connected to the electrode structures. At least one of the electrode structures has a physiological substance extraction pad applied to the mucous membrane. In the present system, the time to apply electric energy to the living body by the power supply device is set between 30 seconds and 20 minutes. The physiological substance extraction pad which is provided in the electrode structure is applicable to the mucous membrane of the mouth and can be used, for example, to monitor glucose in the living body or an amount of drug administered.
Owner:HISAMITSU PHARM CO INC
Vital signals and glucose monitoring personal wireless system
Medical monitoring technologies are integrated with wireless networks to wirelessly send signals from a monitoring device to a cellular telephone or other personal electronic device (PED). A sensor is placed inside or on the patient's body. Information from the monitoring sensor is transmitted to a nearby and / or remote PED. The information transmitted to the PED may then be displayed, processed, stored or forwarded to another location if needed. The monitoring system of the present invention monitors a variety of bodily processes, but preferably measures vital signals such as heart rate, blood pressure, respiration rates, etc. The present invention may also be used to monitor glucose levels in diabetic users. Further, the device may be used as an alert system to alert the patient and third parties when a patient experiences an adverse medical condition.
Owner:RIVAS VICTOR A
Method, System and Computer Program Product for Evaluation of Blood Glucose Variability In Diabetes From Self-Monitoring Data
ActiveUS20090171589A1Long-term riskEnhance existing SMBG devicesHealth-index calculationMedical automated diagnosisLow glucoseRisk profiling
A system, computer program product, method and algorithm for evaluation of blood glucose variability—one of the most important parameters of diabetes management. An embodiment of the method may use routine self-monitoring blood glucose (SMBG) data collected over a period of 2-6 weeks, for example, based on a theory of risk analysis of blood glucose data. One aspect may include a method, system and computer program product for computing the Average Daily Risk Range (ADRR)—a measure of overall glucose variability. Another aspect may include a method, system, and computer program product for estimating separately the glucose variability in the hypoglycemic range via a Low BG Index (LBGI) and the glucose variability in the high BG range via High BG Index (HBGI) followed by a combination of the two indices into a single variability display.
Owner:UNIV OF VIRGINIA ALUMNI PATENTS FOUND
Raman spectroscopy for non-invasive glucose measurements
ActiveUS20070060806A1Error minimizationIncreased signal noiseRadiation pyrometryRaman scatteringMonitor glucoseGlucose Measurement
The present invention relates to the use of Raman spectroscopy for quantitative, non-invasive transcutaneous measurement of blood analytes, such as glucose. Raman spectroscopy is used to measure glucose transcutaneously, in patients whose blood glucose levels were monitored. Raman spectra were collected transcutaneously along with glucose reference values provided by standard capillary blood analysis. A partial least squares calibration was created from the data from each subject and validated using leave-one-out cross validation.
Owner:MASSACHUSETTS INST OF TECH
Methods of monitoring glucose levels in a subject and uses thereof
Methods of frequently monitoring glucose amounts and / or concentrations in a subject who is at risk for hypoglycemia, hyperglycemia, and / or glucose level fluctuations that put the subject at risk are provided. Also provided are methods of monitoring the effects of one or more pharmaceutical compositions on the levels of glucose in a subject.
Owner:ANIMAS TECH
Home test for glycated albumin in saliva
InactiveUS20080227210A1Withdrawing sample devicesVaccination/ovulation diagnosticsSaliva sampleSaliva collection
A home test for measuring glycated albumin levels in saliva. The saliva sample is collected at home using a standardized saliva collection kit and mailed to a testing laboratory that performs the test and reports the result directly back to the customer via the internet. The home test can be used to monitor glucose control in diabetics and in healthy individuals. It may also be used as a diagnostic aid in identifying individuals with diabetes, or who are at risk of developing diabetes.
Owner:SMITH HENRY
Method and implantable system for blood-glucose concentration monitoring using parallel methodologies
ActiveUS20100280348A1Reliable calculationMeasuring blood-glucose concentration reliably and accuratelyElectrocardiographyCatheterConcentrations glucoseMonitor glucose
In an implantable medical device for monitoring glucose concentration in the blood, a blood-glucose concentration analysis is performed using correlations of blood-glucose concentration with measures of metabolic oxygen consumption including oxymetric, and / or temperature. Analysis of electrocardiographic data is used in a parallel method to detect and / or confirm the onset and / or existence and / or extent of hypoglycemia and / or hyperglycemia. Blood-glucose concentration calculation is enhanced by using the combination of the oxygen metabolism analysis and electrocardiographic analysis.
Owner:PACESETTER INC
Nanofibers with high enzyme loading for highly sensitive biosensors
ActiveUS20110229916A1High areaIncrease flexibilityBioreactor/fermenter combinationsBiological substance pretreatmentsFiberEnzyme system
The invention provides high enzyme loading nanofibers and processes utilized in their fabrication, the nanofibers suitable for use as a new class of highly sensitive and stable biosensors capable of monitoring glucose at low levels. The biosensors, comprising nanofiber enzyme materials fabricated from organic solvent-based polymer-enzyme systems, can be used effectively in non-invasive transdermal biosensing applications.
Owner:THE UNIVERSITY OF AKRON
SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors
ActiveUS20070110672A1Detailed informationHigh sensitivityUltrasonic/sonic/infrasonic diagnosticsChemiluminescene/bioluminescenceMetaboliteBoronic acid
Small Molecule Metabolite Reporters (SMMRs) for use as in vivo glucose biosensors, sensor compositions, and methods of use, are described. The SMMRs include boronic acid-containing xanthene, coumarin, carbostyril and phenalene-based small molecules which are used for monitoring glucose in vivo, advantageously on the skin.
Owner:CERCACOR LAB INC
Vital signals and glucose monitoring personal wireless system
InactiveUS20060226991A1Accurate and consistent measurementDiagnostic recording/measuringSensorsMonitor glucoseEngineering
Medical monitoring technologies are integrated with wireless networks to wirelessly send signals from a monitoring device to a cellular telephone or other personal electronic device (PED. A sensor is placed inside or on the patient's body. Information from the monitoring sensor is transmitted to a nearby and / or remote PED. The information transmitted to the PED may then be displayed, processed, stored or forwarded to another location if needed. The monitoring system of the present invention monitors a variety of bodily processes, but preferably measures vital signals such as heart rate, blood pressure, respiration rates, etc. The present invention may also be used to monitor glucose levels in diabetic users. Further, the device may be used as an alert system to alert the patient and third parties when a patient experiences an adverse medical condition.
Owner:RIVAS VICTOR A
Glucose measurement utilizing non-invasive assessment methods
InactiveUS7039447B2Withdrawing sample devicesPhase-affecting property measurementsAnalyteSkin surface
This involves non-invasive glucose measurement processes for determining blood glucose level in the human body. After achieving a static level of glucose at a surface of the skin over some period of time, the glucose may then be measured by a variety of different processes. A sample of the glucose may also first be extracted from the skin and this sample may then be measured. Clearly, these processes are especially suitable for monitoring glucose levels in the human body, and is especially beneficial to users having diabetes mellitus. These procedures may be used for other analyte materials that are found in appropriate regions of the outer skin.
Owner:VIVOMEDICAL INC
Glucose Monitor and Method of Use Thereof
InactiveUS20090156915A1Avoid inconvenienceReduce riskDiagnostic recording/measuringSensorsSteering wheelDriver/operator
An apparatus for monitoring glucose comprising a processor, an indicating mechanism and sensors that are disposed proximate the skin of a person when the skin is in contact with a motor vehicle operational component such as the steering wheel. The apparatus for monitoring glucose measures the driver's glucose concentration via optical coherence tomography or other non-invasive technique, analyzes the driver's glucose concentration via the processor and displays the driver's glucose concentration via the indicator, or alternately sends an alarm signal. The method for monitoring glucose further comprises programming the processor with a range of glucose concentrations, comparing the driver's glucose concentration with the range and signaling an alert if the driver's glucose concentration is outside the range.
Owner:CROSS BILL
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com